Laboratorio Reig Jofre SA is a fully integrated pharmaceutical company founded in 1929 and headquartered in Barcelona, Spain. It specializes in the research, development, manufacture, and marketing of a diverse range of pharmaceutical products, food supplements, and personal care items. Key therapeutic areas include beta-lactams, critical care, dermatology, rheumatology, musculoskeletal disorders, women's health, ENT, podiatrics, sleep-stress OTC disorders, probiotics, and dermo-cosmetics. The company excels in advanced manufacturing technologies such as injectables, freeze-dried, and topical products, alongside nutritional supplements under the Forté Pharma brand and cosmetics. With over 1,300 employees, Laboratorio Reig Jofre SA operates four development and production centers in Europe, including facilities in Toledo, Barcelona, and Sweden, and maintains subsidiaries in nine countries with partnerships across more than 70 nations. It provides comprehensive Contract Development and Manufacturing Organization (CDMO) services, encompassing drug product formulation, aseptic fill-finish, clinical trial materials, packaging, and regulatory support, holding approvals from EMA, GMP, PMDA, Health Canada, and ANVISA. As a subsidiary of Reig Jofre Investments SL, it plays a significant role in the global pharmaceutical and biotech sectors, focusing on small molecules and biologics.
Leadership (11)
Andy ZolperChief Information Officer
Katherine H. LarsonChief Accounting Officer
Kristina WaughSenior Vice President of Investor Relations and FP&A
Jonathan N. SantelliExecutive Vice President, General Counsel & Corporate Secretary
Tashtego Spring ElwynPresident of Private Client Group
Bella Loykhter AllaireChief Administrative Officer
Scott Alan CurtisChief Operating Officer
James E. BunnPresident of Capital Markets & Advisory
Jonathan W. Oorlog Jr.Senior Vice President, Chief Financial Officer & Controller
Paul Christopher ReillyExecutive Chair
Paul Marone ShoukryChief Executive Officer & Director